• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于治疗结节性硬化症面部血管纤维瘤的新型外用雷帕霉素乳膏。

A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.

作者信息

Wheless James W, Almoazen Hassan

机构信息

Division of Pediatric Neurology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38105, USA.

出版信息

J Child Neurol. 2013 Jul;28(7):933-6. doi: 10.1177/0883073813488664. Epub 2013 May 16.

DOI:10.1177/0883073813488664
PMID:23680945
Abstract

Facial angiofibromas are dermatological manifestations of tuberous sclerosis complex, a neurocutaneous disorder characterized by excess cell growth and proliferation. Oral rapamycin has been used to treat visceral tuberous sclerosis-related tumors; however, the side effect profile of this medicine precludes its routine use in patients lacking significant internal involvement. The authors formulated a novel rapamycin cream that is easy to compound and apply, does not cause local or systemic side effects, and results in a dramatic improvement of facial angiofibromas.

摘要

面部血管纤维瘤是结节性硬化症的皮肤表现,结节性硬化症是一种神经皮肤疾病,其特征是细胞过度生长和增殖。口服雷帕霉素已被用于治疗与内脏结节性硬化症相关的肿瘤;然而,这种药物的副作用限制了它在没有严重内部受累患者中的常规使用。作者配制了一种新型雷帕霉素乳膏,它易于配制和应用,不会引起局部或全身副作用,并且能显著改善面部血管纤维瘤。

相似文献

1
A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.一种用于治疗结节性硬化症面部血管纤维瘤的新型外用雷帕霉素乳膏。
J Child Neurol. 2013 Jul;28(7):933-6. doi: 10.1177/0883073813488664. Epub 2013 May 16.
2
Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.结节性硬化症面部血管纤维瘤局部使用雷帕霉素治疗的当前数据分析。
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):14-20. doi: 10.1111/jdv.12665. Epub 2014 Aug 29.
3
Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.外用雷帕霉素:治疗结节性硬化症面部血管纤维瘤的新方法。
Arch Dermatol. 2010 Jul;146(7):715-8. doi: 10.1001/archdermatol.2010.125.
4
Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis.两名结节性硬化症患者局部应用口服雷帕霉素溶液(1mg/mL)治疗面部血管纤维瘤。
Br J Dermatol. 2011 Oct;165(4):922-3. doi: 10.1111/j.1365-2133.2011.10476.x.
5
[Facial angiofibromas associated to tuberous sclerosis treated with topical sirolimus].[外用西罗莫司治疗与结节性硬化症相关的面部血管纤维瘤]
Ugeskr Laeger. 2013 Oct 21;175(43):2569-70.
6
First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex.首项雷帕霉素与赋形剂治疗结节性硬化症患者面部血管纤维瘤的左右对比研究。
Br J Dermatol. 2013 Dec;169(6):1314-8. doi: 10.1111/bjd.12567.
7
Topical 0.2% rapamycin to treat facial angiofibromas and hypomelanotic macules in tuberous sclerosis.外用0.2%雷帕霉素治疗结节性硬化症的面部血管纤维瘤和色素减退斑。
Actas Dermosifiliogr. 2014 Oct;105(8):802-3. doi: 10.1016/j.ad.2013.09.013. Epub 2013 Dec 17.
8
Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions.局部应用雷帕霉素治疗结节性硬化症患儿的血管纤维瘤:一项试点研究的随访及前景广阔的未来方向
Australas J Dermatol. 2014 Feb;55(1):63-9. doi: 10.1111/ajd.12125. Epub 2013 Dec 22.
9
Retrospective study of rapamycin or rapalog 0·1% cream for facial angiofibromas in tuberous sclerosis complex: evaluation of treatment effectiveness and cost.西罗莫司或0.1%雷帕霉素类似物乳膏治疗结节性硬化症面部血管纤维瘤的回顾性研究:治疗效果及成本评估
Br J Dermatol. 2018 Jul;179(1):208-209. doi: 10.1111/bjd.16397. Epub 2018 May 7.
10
A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.局部应用雷帕霉素和他克莫司联合治疗结节性硬化症相关的血管纤维瘤:一项不同疾病严重程度的 9 例日本结节性硬化症患者的初步研究
Br J Dermatol. 2011 Oct;165(4):912-6. doi: 10.1111/j.1365-2133.2011.10471.x.

引用本文的文献

1
Effective Technique Using Combined CO Laser and Pulsed Dye Laser for Facial Angiofibromas Management in Tuberous Sclerosis.联合使用二氧化碳激光和脉冲染料激光治疗结节性硬化症面部血管纤维瘤的有效技术
Case Rep Dermatol Med. 2024 Sep 16;2024:9775613. doi: 10.1155/2024/9775613. eCollection 2024.
2
Rapamycin and rapalogs for tuberous sclerosis complex.雷帕霉素及其类似物治疗结节性硬化症。
Cochrane Database Syst Rev. 2023 Jul 11;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub3.
3
Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge.
结节性硬化症患者的监测与管理:当前知识现状
J Multidiscip Healthc. 2022 Jul 14;15:1469-1480. doi: 10.2147/JMDH.S266990. eCollection 2022.
4
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.0.1%雷帕霉素亲水凝胶治疗面部血管纤维瘤的长期稳定性。
Eur J Hosp Pharm. 2020 Mar;27(e1):e48-e52. doi: 10.1136/ejhpharm-2018-001695. Epub 2018 Nov 10.
5
Rapamycin for the aging skin.雷帕霉素用于抗皮肤衰老。
Aging (Albany NY). 2019 Dec 27;11(24):12822-12826. doi: 10.18632/aging.102664.
6
Correlative imaging of ionic transport and electronic structure in nano LiFePO electrodes.纳米 LiFePO 电极中离子输运和电子结构的相关成像。
Chem Commun (Camb). 2020 Jan 18;56(6):984-987. doi: 10.1039/c9cc09116e. Epub 2019 Dec 20.
7
Long-Term Exposure and Safety of a Novel Topical Rapamycin Cream for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex: Results From a Single-Center, Open-Label Trial.一种新型外用雷帕霉素乳膏治疗结节性硬化症面部血管纤维瘤的长期暴露与安全性:一项单中心、开放标签试验的结果
Child Neurol Open. 2019 Apr 14;6:2329048X19835047. doi: 10.1177/2329048X19835047. eCollection 2019.
8
Tuberous sclerosis complex: review based on new diagnostic criteria.结节性硬化症复合体:基于新诊断标准的综述
An Bras Dermatol. 2018 Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972.
9
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.局部他莫昔芬治疗结节性硬化症相关面血管纤维瘤的疗效和安全性:一项 TREATMENT 随机临床试验。
JAMA Dermatol. 2018 Jul 1;154(7):773-780. doi: 10.1001/jamadermatol.2018.0464.
10
Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?mTOR抑制剂对结节性硬化症(TSC)患者的所有肿瘤治疗是否足够有效?
J Cancer. 2016 Jul 21;7(12):1621-1631. doi: 10.7150/jca.14747. eCollection 2016.